R&D channel feed – Endpoints News

R&D channel feed

Applied Molecular Transport prepares to close up shop as it pauses R&D, replaces CEO, lays off 57%

3 years ago

Merck touts PhIII Keytruda data in frontline endometrial cancer

3 years ago

Gamida Cell makes more staff cuts and restructures as it focuses on potential drug launch

3 years ago

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

3 years ago

Who’s spending and who’s cutting from Big Pharma’s $127B R&D budget? Here are the top 15 players

3 years ago

AstraZeneca, Ionis boast full PhIII win for ATTR drug under review

3 years ago

Codiak files for Chapter 11 bankruptcy as most executives head for the exit

3 years ago

With one of biotech's largest private rounds in a year, ArriVent enters PhIII

3 years ago

Another biotech startup runs into a PhII pileup in Parkinson's

3 years ago

BrainStorm gets FDA adcomm for ALS drug after failed trial and RTF

3 years ago

Updated: FDA approves Pharming drug for ultra-rare immunodeficiency disease

3 years ago

Novo Nordisk oral semaglutide trial shows reduction in blood sugar, plus weight loss

3 years ago

Lyme vaccine test completion is pushed back by a year as Pfizer, Valneva say they'll adjust trial

3 years ago

AbbVie says it has positive mid-stage data for Rinvoq in lupus, will move to PhIII

3 years ago

FDA spells out how cancer drug developers can use one trial for both accelerated and full approvals

3 years ago

Relmada makes 'critical changes' to PhIII trial to try and save depression drug

3 years ago

Hard pressed for cash, Cyclerion looks for help funding rare disease drug

3 years ago

Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request

3 years ago

Moderna partners on non-viral gene therapy with Generation Bio after swinging gene editing deals

3 years ago

Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful

3 years ago

FDA approves Cidara's Rezzayo as antifungal treatment for candidemia and invasive candidiasis

3 years ago

Sanofi, Regeneron boast PhIII win with Dupixent in COPD, clearing first bar for expansion

3 years ago

Regeneron scores label expansion for cholesterol drug Evkeeza

3 years ago

Novartis pulls the plug on UK-based cardiovascular study

3 years ago

First page Previous page 91 92 939495 96 97 Next page Last page